Korea United Pharm Inc
KRX:033270

Watchlist Manager
Korea United Pharm Inc Logo
Korea United Pharm Inc
KRX:033270
Watchlist
Price: 18 130 KRW -1.15%
Market Cap: 266.7B KRW

Wall Street
Price Targets

Price Targets Summary
Korea United Pharm Inc

Wall Street analysts forecast Korea United Pharm Inc stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Korea United Pharm Inc is 29 580 KRW with a low forecast of 28 280 KRW and a high forecast of 31 500 KRW.

Lowest
Price Target
28 280 KRW
56% Upside
Average
Price Target
29 580 KRW
63% Upside
Highest
Price Target
31 500 KRW
74% Upside
Korea United Pharm Inc Competitors:
Price Targets

Revenue
Forecast

5% / Year
Past Growth
3% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
5% / Year
Past Growth
3% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

For the last 13 years the compound annual growth rate for Korea United Pharm Inc's revenue is 5%. The projected CAGR for the next 3 years is 3%.

Operating Income
Forecast

6% / Year
Past Growth
1% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
6% / Year
Past Growth
1% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

For the last 13 years the compound annual growth rate for Korea United Pharm Inc's operating income is 6%. The projected CAGR for the next 3 years is 1%.

Net Income
Forecast

4% / Year
Past Growth
13% / Year
Estimated Growth
Estimates Accuracy
10%
Average Beat
4% / Year
Past Growth
13% / Year
Estimated Growth
Estimates Accuracy
10%
Average Beat

For the last 13 years the compound annual growth rate for Korea United Pharm Inc's net income is 4%. The projected CAGR for the next 3 years is 13%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Korea United Pharm Inc's stock price target?
Price Target
29 580 KRW

According to Wall Street analysts, the average 1-year price target for Korea United Pharm Inc is 29 580 KRW with a low forecast of 28 280 KRW and a high forecast of 31 500 KRW.

What is Korea United Pharm Inc's Revenue forecast?
Projected CAGR
3%

For the last 13 years the compound annual growth rate for Korea United Pharm Inc's revenue is 5%. The projected CAGR for the next 3 years is 3%.

What is Korea United Pharm Inc's Operating Income forecast?
Projected CAGR
1%

For the last 13 years the compound annual growth rate for Korea United Pharm Inc's operating income is 6%. The projected CAGR for the next 3 years is 1%.

What is Korea United Pharm Inc's Net Income forecast?
Projected CAGR
13%

For the last 13 years the compound annual growth rate for Korea United Pharm Inc's net income is 4%. The projected CAGR for the next 3 years is 13%.

Back to Top